DiviDrip · BCTXZ

BCTXZ — BriaCell Therapeutics Corp. Warrant

Stock Warrant

WARRANT

BriaCell Therapeutics Corp. Warrant

Underlying stock
Exercise price
Exchange
To Break-Even
Expires In2030-04-28

No redemption notice detected. Our weekly 8-K watcher runs every Friday and stamps this card if the issuer files a redemption 8-K.

$
Break-even (underlying)
Unrealized P/L
Intrinsic value
$0.00
max(0, underlying − strike)
Time value
$0.14
warrant price − intrinsic

BCTXZ is BriaCell Therapeutics Corp. Warrant (Healthcare) — a non-dividend-paying stock. Trading at $0.14. Capital Quality Rank: 43/100 — Stagnant mediocrity.

Stock snapshot

Price$0.14
Market cap
SectorHealthcare
ExchangeXNAS
Pays dividendNo

Capital Quality & fundamentals

DiviDrip's Capital Analytics engine ranks every non-dividend stock 1-100 on a 4-factor composite (Shareholder Yield 30%, Cash-Flow ROI 25%, Operating Momentum 25%, Tail-Risk 20%) — sector-neutralized so a biotech isn't penalized for negative earnings the way a utility would be.

Capital Quality Rank (1-100)43 / 100 · Stagnant mediocrity
ROIC (TTM)-68.5%
Shareholder buyback yield0.00%
Altman Z-score zoneDistress

About BCTXZ

BriaCell Therapeutics Corp is a clinical-stage biotechnology company focused on developing immunotherapies for cancer treatment, particularly breast cancer. The company's targeted immunotherapy program, Bria-IMT, is a targeted cell-based immunotherapy in end-stage clinical trials aiming to improve outcomes for patients with breast cancer. BriaCell also develops Bria-OTS, personalized off-the-shelf immunotherapies for breast and prostate cancer. BriaCell is involved in clinical collaborations to explore combination therapies for enhanced cancer treatment options.

Listed2025Employees4HQWest Vancouver, A1SectorHealthcareWebsitebriacell.com

Related non-dividend companies

Other non-dividend stocks investors research alongside BCTXZ. Peer set from Massive news + returns similarity, filtered to names we currently track.

Frequently asked

What is BCTXZ's current stock price?

BCTXZ (BriaCell Therapeutics Corp. Warrant) is currently trading at $0.14.

Does BCTXZ pay a dividend?

BCTXZ (BriaCell Therapeutics Corp. Warrant) does not currently pay a regular dividend.

What is BCTXZ's Capital Quality Rank?

BCTXZ has a Capital Quality Rank of 43/100 — Stagnant mediocrity. This score blends ROIC, revenue growth, buybacks, and balance-sheet health.

Track BCTXZ in DiviDrip

Add BCTXZ to your watchlist on DiviDrip to monitor price, fundamentals, and Capital Quality Rank week-over-week. Built for long-term investors tracking both dividend and non-dividend names.

Data refreshed 2026-08-30. Not investment advice. Prices change continuously; always verify the latest numbers in the live app before buying.

Related guides

DiviDrip is a free dividend portfolio tracker built by dividend investors, for dividend investors. Try it free — no payment, no upsell, ever. Read the How-To to see how each tool fits together, or browse the Glossary for every term defined plain-English.

Disclaimer: The information provided on this website/service is for informational purposes only and does not constitute financial, investment, or legal advice. Investing in stocks involves high risk, including the loss of principal. We are not responsible for any financial losses or damages resulting from your reliance on this data. Always consult with a qualified financial professional before making investment decisions.

Trademark Notice: Twylight Crow's Dividend Tracker (formerly indexed as DiviDrip) is an independent portfolio utility. This tool is not affiliated with, authorized, endorsed by, or in any way officially connected to Dividrip.com or its international affiliates.

Contact: dividrip@twylightcrow.com© 2026 Twylight Crow